The World Health Organization (WHO) is the subject of a new investigation aimed at uncovering what really took place during the 2009 global influenza pandemic, which led to tens of millions of people being vaccinated for so-called “swine flu.” A joint investigation by the British Medical Journal (BMJ) and the Bureau of Investigative Journalism (BIJ) has already uncovered major conflicts of interest at WHO, whereby vaccine companies profited heavily from the pandemic and the mass hysteria that it generated.
The investigation is focused specifically on the emergency advisory committee that was assigned to make official recommendations to WHO about how to plan for the pandemic, which was fraught with controversy from the start. Comprising this advisory panel were individuals highly connected to pharmaceutical companies, say BMJ and BIJ, many of whom had a vested financial interest in promoting antiviral drugs and influenza vaccines, which have been linked to causing narcolepsy and other disorders.
Big Pharma reportedly held a $4 billion stake in developing the swine flu vaccines that WHO would later push on the public through propaganda and fear. And the reason that WHO so readily accepted these drugs as viable responses to the pandemic is because its key advisors, many of whom are still unknown because they were intentionally kept secret, worked on behalf of the vaccine industry to see these drugs thrust into the limelight of the pandemic-planning process.
“Key scientists advising the World Health Organization on planning for an influenza pandemic had done paid work for pharmaceutical firms that stood to gain from the guidance they were preparing,” reads a report on the joint investigation. “These conflicts of interest have never been publicly disclosed by WHO, and WHO has dismissed inquiries into its handling of the A/H1N1 pandemic as ‘conspiracy theories.'”
Flu pandemic hysteria led to governments purchasing huge stockpiles of drugs, vaccines that were never used
The ultimate goal, of course, was to convince as many governments around the world as possible to purchase large stockpiles of antiviral drugs like oseltamivir (Tamiflu) and zanamivir (Relenza), and vaccines like Pandemrix, to generate massive profits. Some of these drugs had never even been proven to work, let alone proven safe, and yet they were widely distributed as the emergency “cure” for H1N1.
Both oseltamivir and zanamivir have been around since the late 1990s, but the U.S. Food and Drug Administration (FDA) and other regulators really had to stretch the flimsy data that they received on the two drugs from their respective manufacturers in order to approve them. The FDA, it turns out, initially opposed recommending zanamivir, manufactured by GlaxoSmithKline, during the pandemic, because the data on its safety and efficacy was severely lacking — the agency later changed it’s mind.
“After Dr [Michael] Elashoff’s review (he had access to individual patient data and summary study reports) the FDA’s advisory committee voted by 13 to 4 not to approve zanamivir on the grounds that it was no more effective than placebo when the patients were on other drugs such as paracetamol,” adds the report. “Dr Elashoff’s view was that zanamivir was no better than placebo — and it had side effects.”
The pandemic, as most people now know, ultimately turned out to be a complete flop. Many individuals ended up rejecting both the drugs and the vaccines that were being pushed on them by the government, which means that these taxpayer-purchased drugs and vaccines are now sitting unused and on the verge of expiration in warehouses all across the globe.
You can read a full report of the joint investigation by BMJ and BIJ into WHO corruption during the 2009 H1N1 pandemic by visiting:
Sources for this article include: